Reported Dec 27, 2017 · Terminated

Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only…

Premier Pharmacy Labs Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Premier Pharmacy Labs Inc · 8265 Commercial Way · Weeki Wachee, FL · 34613-4511

Is this the product you have?

  • Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable
  • Hospital/Office Use Only Compounded by
    • Premier Pharmacy Labs
    • Inc. 8265 Commercial Way Weeki Wachee
    • FL 34613
    • NDC# 69623-234-15
Lot codes and dates
  • Lot #
  • NEO071317MMDSA BUD01/19/2018 Lot #
  • NEO071317MMDSC BUD01/19/2018 Lot #
  • NEO071317MMDSF BUD01/19/2018
Amount recalled
1610 syringes

Where it was sold

Why it was recalled

Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Premier Pharmacy Labs Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 29, 2018 · Data as of Sep 19, 7:15 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.